Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas : significance of cell adhesion and epithelial–mesenchymal transition-related signaling pathways (本文)

1. Van, C.E. et al. (2016) Gastric cancer. Lancet, 388, 2654–2664.

2. Ferro, A. et al. (2014) Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype. Eur. J. Cancer, 50, 1330–1344.

3. Jones, P.A. et al. (2016) Targeting the cancer epigenome for therapy. Nat. Rev. Genet., 17, 630–641.

4. Watari, J. et al. (2019) DNA methylation silencing of microRNA gene methylator in the precancerous background mucosa with and without gastric cancer: analysis of the effects of H. pylori eradication and long-term aspirin use. Sci. Rep., 9, 12559.

5. Tsumura, K. et al. (2019) Establishment of permutation for cancer risk estimation in the urothelium based on genome-wide DNA methylation analysis. Carcinogenesis, 40, 1308–1319.

6. Kuramoto, J. et al. (2017) Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis. Carcinogenesis, 38, 261–270.

7. Ohara, K. et al. (2017) Genes involved in development and differentiation are commonly methylated in cancers derived from multiple organs: a single-institutional methylome analysis using 1007 tissue specimens. Carcinogenesis, 38, 241–251.

8. Mizuguchi, A. et al. (2018) Genetic features of multicentric/multifocal intramucosal gastric carcinoma. Int. J. Cancer, 143, 1923–1934.

9. Kaneda, A. et al. (2012) Epstein-Barr virus infection as an epigenetic driver of tumorigenesis. Cancer Res., 72, 3445–3450.

10. Arai, E. et al. (2015) Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas. Int. J. Cancer, 137, 2589–2606.

11. Sato, T. et al. (2014) Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: its correlation with smoking history and chronic obstructive pulmonary disease. Int. J. Cancer, 135, 319–334.

12. Kanai, Y. et al. (2014) Multilayer-omics analyses of human cancers: exploration of biomarkers and drug targets based on the activities of the International Human Epigenome Consortium. Front. Genet., 5, 24.

13. Yamanoi, K. et al. (2015) Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome. Carcinogenesis, 36, 509–520.

14. Oue, N. et al. (2019) Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells. Int. J. Clin. Oncol., 24, 771–778.

15. Zhang, J. et al. (2018) Genomic alterations in gastric cancers discovered via whole-exome sequencing. BMC Cancer, 18, 1270.

16. Vogelaar, I.P. et al. (2017) Unraveling genetic predisposition to familial or early onset gastric cancer using germline whole-exome sequencing. Eur. J. Hum. Genet., 25, 1246–1252.

17. Chen, K. et al. (2015) Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. Proc. Natl. Acad. Sci. U.S.A., 112, 1107–1112.

18. Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of gastric adenocarcinoma. Nature, 513, 202–209.

19. Fukayama, M. et al. (2019) Tumours of the stomach. In The WHO Classification of Tumours Editorial Board (ed) WHO Classification of Tumours of Digestive System Tumours. 5th edn. Vol.1. IARC Press, Lyon, France, pp. 59–104.

20. Wittekind, C.H. et al. (2017) Stomach. In Brierley, J.D., Gospodarowicz, M.K. and Wittekind, C. (eds) TNM Classification of Malignant Tumours. 8th edn. Wiley-Blackwell Press, Hoboken, NJ, pp. 63–66.

21. Kanai, Y. et al. (2018) The Japanese Society of Pathology guidelines on the handling of pathological tissue samples for genomic research: standard operating procedures based on empirical analyses. Pathol. Int., 68, 63–90.

22. Li, H. et al. (2010) Fast and accurate long-read alignment with burrowswheeler transform. Bioinformatics, 26, 589–595.

23. McKenna, A. et al. (2010) The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res., 20, 1297–1303.

24. Cibulskis, K. et al. (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol., 31, 213–219.

25. Ng, P.C. et al. (2003) SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res., 31, 3812–3814.

26. Hicks, S. et al. (2011) Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed. Hum. Mutat., 32, 661–668.

27. Sim, N.L. et al. (2012) SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res., 40(Web Server issue), W452–W457.

28. Van, L.P. et al. (2010) Allele-specific copy number analysis of tumors. Proc. Natl. Acad. Sci. U.S.A., 107, 16910–16915.

29. Li, A. et al. (2011) GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays. Nucleic Acids Res., 39, 4928–4941.

30. Quinlan, A.R. et al. (2010) BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics, 26, 841–842.

31. Niell, N. et al. (2018) The human PKP2/plakophilin-2 gene is induced by Wnt/β-catenin in normal and colon cancer-associated fibroblasts. Int. J. Cancer, 142, 792–804.

32. Zhou, X. et al. (2020) Genome-wide CRISPR knockout screens identify ADAMTSL3 and PTEN genes as suppressors of HCC proliferation and metastasis, respectively. J. Cancer Res. Clin. Oncol., 146, 1509–1521.

33. Li, X. et al. (2019) MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/βcatenin axis in non-small-cell lung cancer. Cancer Sci., 110, 1883–1896.

34. Arai, E. et al. (2012) Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas. Carcinogenesis, 33, 1487–1493.

35. Jones, P.A. et al. (2009) Rethinking how DNA methylation patterns are maintained. Nat. Rev. Genet., 10, 805–811.

36. Makabe, T. et al. (2019) Genome-wide DNA methylation profile of earlyonset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer. Carcinogenesis, 40, 611–623.

37. Arimoto, K. et al. (2014) Plakophilin-2 promotes tumor development by enhancing ligand-dependent and -independent epidermal growth factor receptor dimerization and activation. Mol. Cell. Biol., 34, 3843–3854.

38. Takahashi, H. et al. (2012) Up-regulation of plakophilin-2 and Downregulation of plakophilin-3 are correlated with invasiveness in bladder cancer. Urology, 79, 240.e1–240.e8.

39. Srivastava, S. et al. (2020) An LCM-based genomic analysis of SPEM, gastric cancer and pyloric gland adenoma in an Asian cohort. Mod. Pathol. doi: 10.1038/s41379-020-0520-5.

40. Chen, J. et al. (2020) Evidence for heightened genetic instability in precancerous spasmolytic polypeptide expressing gastric glands. J. Med. Genet., 57, 385–388.

41. Wong, S.S. et al. (2014) Genomic landscape and genetic heterogeneity in gastric adenocarcinoma revealed by whole-genome sequencing. Nat. Commun., 5, 5477.

42. Kakiuchi, M. et al. (2014) Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat. Genet., 46, 583–587.

43. Gaudet, F. et al. (2003) Induction of tumors in mice by genomic hypomethylation. Science, 300, 489–492.

44. Hirohashi, S. et al. (2003) Cell adhesion system and human cancer morphogenesis. Cancer Sci., 94, 575–581.

45. Moirangthem, A. et al. (2016) Simultaneous knockdown of uPA and MMP9 can reduce breast cancer progression by increasing cell-cell adhesion and modulating EMT genes. Sci. Rep., 6, 21903.

46. Thapa, N. et al. (2017) PIPKIγ and talin couple phosphoinositide and adhesion signaling to control the epithelial to mesenchymal transition. Oncogene, 36, 899–911.

47. Shi, D. et al. (2019) LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ ROCK1/p38MAPK/Twist1 signaling pathway. J. Exp. Clin. Cancer Res., 38, 375.

48. Tong, X. et al. (2020) MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancer. Oncogene, 39, 2890–2904.

49. Yang, J. et al. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927–939.

50. Marofi, F. et al. (2019) Gene expression of TWIST1 and ZBTB16 is regulated by methylation modifications during the osteoblastic differentiation of mesenchymal stem cells. J. Cell. Physiol., 234, 6230–6243.